ArticleCase reports in oncology
Sustained Remission following Lung Resection of Isolated Pulmonary Stage III Epithelioid Trophoblastic Tumor: A Case Report.
Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Primary cervical choriocarcinoma: a case report.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Epithelioid trophoblastic tumor (ETT) is a rare form of gestational trophoblastic disease (GTD) that primarily affects women of reproductive age. The presence of extrauterine ETT poses additional challenges in management, as treatment guidelines remain inconsistent. Fertility preservation is often a key consideration in this patient population. This article highlights a case of ETT with isolated sole site metastasis to the lower lobe of the left lung. It was successfully managed with surgical resection, leading to sustained remission in a premenopausal woman desiring future pregnancies. Case Presentation: A 34-year-old woman (G2P1011) presented with persistent low-level beta-human chorionic gonadotropin (β-HCG) elevation for over 3 years with no clear underlying cause. She was being followed by her primary gynecologist for a menstrual abnormality, reporting the passage of "grape-like" clots with menses, but was otherwise asymptomatic. Initial workup spanning 2019-2020 including pelvic ultrasound, magnetic resonance imaging (MRI) of the brain and pelvis, and positron emission tomography-computed tomography (PET-CT) were negative for radiographic abnormalities. When the β-HCG level notably increased in 2023, the patient was treated at an outside hospital with three doses of methotrexate for presumed ectopic pregnancy. Her β-HCG levels remained elevated despite this treatment. Follow-up skull-base-to-mid-thigh PET-CT revealed a lobulated hypermetabolic nodule in the superior segment of the left lower lobe of the lung. No other disease was identified on PET-CT, pelvic US, or MRI brain. The patient underwent a video-assisted thoracoscopic surgery wedge resection, and pathological analysis confirmed ETT. Within 2 weeks postoperatively, her β-HCG levels declined to <3.0 mIU/mL and have remained undetectable for 18 months. Conclusion: ETTs are among the rarest forms of GTD. ETT rarely presents outside the uterus and often demonstrates poor response to chemotherapy. This case report highlights a unique presentation of primary pulmonary ETT, successfully managed with surgical resection alone, achieving sustained remission without chemotherapy. In women of reproductive age with persistently elevated β-HCG levels of unclear origin, ETT should remain a consideration. While surgical management may be a viable treatment option for tumors with sole site metastasis, close postoperative monitoring is essential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.